The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits
Open accessAbstract
Overexpression of MYC transforms cells in culture, elicits malignant tumours in experimental animals and is found in many human tumours. We now report the paradoxical finding that this powerful oncogene can also act as a suppressor of cell motility, invasiveness and metastasis. Overexpression of MYC stimulated proliferation of breast cancer cells both in culture and in vivo as expected, but inhibited motility and invasiveness in culture, and lung and liver metastases in xenografted tumours. We show further that MYC represses transcription of both subunits of αvβ3 integrin, and that exogenous expression of β3 integrin in human breast cancer cells that do not express this integrin rescues invasiveness and migration when MYC is downregulated. These data uncover an unexpected function of MYC, provide an explanation for the hitherto puzzling literature on the relationship between MYC and metastasis, and reveal a variable that could influence the development of therapies that target MYC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent report has found that MYC overexpression leads to a direct downregulation of ITGB3, inducing decreased motility and invasiveness (Liu et al., 2012).”
From Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway (2017) · cites this paper as Liu et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Migration: Integrating Signals from Front to Back
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R., Ginsberg, M. H., Borisy, G. G., Parsons, J. T., & Horwitz, A. R. (2003) · Science · doi:10.1126/science.1092053 · Cited by 5,109
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1075 · Cited by 3,350
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc727 · Cited by 1,798
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,722
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,522
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J. J., Prabhala, H. K., Pan, E., Mestdagh, P., Muth, D., Teruya‐Feldstein, J., Reinhardt, F., Önder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,358
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Systemic Spread Is an Early Step in Breast Cancer
Hüsemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T. N., Riethmüller, G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.003 · Cited by 1,220
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–181 of 181
New Insights into the Activities of D-Chiro-Inositol: A Narrative Review
Gambioli, R., Oliva, M. M., Nordio, M., Chiefari, A., Puliani, G., & Unfer, V. (2021) · Biomedicines · doi:10.3390/biomedicines9101378 · Cited by 26
Regulation of integrin αV subunit expression by sulfatide in hepatocellular carcinoma cells
Wu, W., Dong, Y. W., Shi, P., Yu, M., Fu, D., Zhang, C. Y., Cai, Q., Zhao, Q. L., Peng, M., Wu, L. H., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m031450 · Cited by 26
Intratumour oxidative hotspots provide a niche for cancer cell dissemination
Ueda, Y., Kiyonaka, S., Selfors, L. M., Inoue, K., Harada, H., Doura, T., Onuma, K., Uchiyama, M., Kurogi, R., Yamada, Y., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01617-w · Cited by 28
Kim, Y., Muthuramalingam, K., & Cho, M. (2020) · Cells · doi:10.3390/cells9061555 · Cited by 24
MicroRNA hsa-let-7e-5p as a potential prognosis marker for rectal carcinoma with liver metastases
Chen, W., Lin, G., Yao, Y., Chen, J., Shui, H., Yang, Q., Wang, X., Weng, X., Sun, L. V., Chen, F., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8181 · Cited by 24
Pourteimoor, V., Paryan, M., & Mohammadi‐Yeganeh, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26399 · Cited by 24
Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells
Jing, H., Liaw, L., Friesel, R. E., Vary, C., Hua, S., & Yang, X. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0292-7 · Cited by 23
Recognizing Paradigm Instability in Theories of Carcinogenesis
Baker, S. G. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/6855 · Cited by 26
Bhartiya, D., Raouf, S., Pansare, K., Tripathi, A., & Tripathi, A. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10694-7 · Cited by 21
The association between autosomal dominant polycystic kidney disease and cancer
Sun, K., Xu, D., & Mei, C. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1951-5 · Cited by 20
Regulation of sex hormone receptors in sexual dimorphism of human cancers
Zheng, D., Williams, C., Vold, J. A., Nguyen, J. H., Harnois, D. M., Bagaria, S. P., McLaughlin, S. A., & Li, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.001 · Cited by 20
Juengel, E., Makarević, J., Reiter, M., Mani, J., Tsaur, I., Bartsch, G. C., Haferkamp, A., & Blaheta, R. A. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.011 · Cited by 20
Amgalan, B., & Lee, H. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv175 · Cited by 20
MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer
Cichon, M. A., Moruzzi, M. E., Shqau, T. A., Miller, E. E., Mehner, C., Ethier, S. P., Copland, J. A., Radisky, E. S., & Radisky, D. C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3465 · Cited by 19
Self-citationLal, S., Kersch, C. N., Beeson, K. A., Wu, Y. J., Muldoon, L. L., & Neuwelt, E. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131842 · Cited by 18
Suseela, Y. V., Sengupta, P., Roychowdhury, T., Panda, S., Talukdar, S., Chattopadhyay, S., Chatterjee, S., & Govindaraju, T. (2021) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.1c00039 · Cited by 18
Blacklock, K. B., Birand, Z., Biasoli, D., Fineberg, E., Murphy, S., Flack, D., Bass, J., Palma, S. D., Blackwood, L., McKay, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208026 · Cited by 18
Molecular understanding of lung cancers–A review
Singh, C. R., & Kathiresan, K. (2014) · Asian Pacific Journal of Tropical Biomedicine · doi:10.12980/apjtb.4.2014c597 · Cited by 18
Moritz, M. N. D. O., Eustáquio, L. M. S., Micocci, K. C., Nunes, A. C. C., dos Santos, P. K., Vieira, T. D. C., & Selistre-de-Araújo, H. S. (2018) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/s40409-018-0150-2 · Cited by 17
Vergara, D., Ravaioli, S., Fonzi, E., Adamo, L., Damato, M., Bravaccini, S., Pirini, F., Gaballo, A., Barbano, R., Pasculli, B., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030715 · Cited by 17
MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging
Grieb, B. C., & Eischen, C. M. (2022) · Biology · doi:10.3390/biology11060881 · Cited by 18
Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc
Lee, M., Program, N. C. S., Beggs, S. M., Gildea, D. E., Bupp, S., Lichtenberg, J., Trivedi, N. S., Hu, Y., Bodine, D. M., & Crawford, N. P. S. (2015) · Oncotarget · doi:10.18632/oncotarget.5230 · Cited by 16
Luo, A., Zhang, X., Fu, L., Zhu, Z., & Dong, J. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.05.006 · Cited by 16
de Camargo, M. S., de Oliveira, M. T., Santoni, M. M., Resende, F. A., Oliveira-Höhne, A. P., Espanha, L. G., Nogueira, C., Cuesta‐Rubio, O., Vilegas, W., & Varanda, E. A. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.11.007 · Cited by 16
Bhat, J., Mondal, S., Sengupta, P., & Chatterjee, S. (2017) · ACS Omega · doi:10.1021/acsomega.6b00531 · Cited by 15
Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods
Tuo, Y., An, N., & Zhang, M. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8398 · Cited by 15
PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells
Symonds, J. M., Ohm, A. M., Tan, A. C., & Reyland, M. E. (2016) · Oncotarget · doi:10.18632/oncotarget.7560 · Cited by 15
Levy, D. R. S., Udgata, A., Tourlomousis, P., Symmons, M. F., Hopkins, L., Bryant, C. E., & Gay, N. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011842 · Cited by 14
Rekowska, A. K., Obuchowska, K., Bartosik, M., Kimber-Trojnar, Ż., Słodzińska, M., Wierzchowska-Opoka, M., & Leszczyńska‐Gorzelak, B. (2023) · Cancers · doi:10.3390/cancers15092618 · Cited by 13
Coşkunpınar, E. M., Oltulu, Y. M., Orhan, K. S., Tiryakioğlu, N. O., Kanliada, D., & Akbaş, F. (2013) · Gene · doi:10.1016/j.gene.2013.10.063 · Cited by 13
Unlocking the mysterious mechanisms of Myc
(2013) · Nature Medicine · doi:10.1038/nm.3060 · Cited by 13
ZNF121 interacts with ZBRK1 and BRCA1 to regulate their target genes in mammary epithelial cells
Luo, A., Zhang, K., Zhao, Y., Zhu, Z., Fu, L., & Dong, J. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12530 · Cited by 13
Oliphant, M. U. J., Kong, D., Zhou, H., Lewis, M. T., & Ford, H. L. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09449-0 · Cited by 13
Derouet, M. F., Dakpo, E., Wu, L., Zehong, G., Conner, J., Keshavjee, S. H., de Perrot, M. E., Waddell, T. K., Elimova, E. C., Yeung, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24613 · Cited by 13
Targeting oncogene-induced cellular plasticity for tumor therapy
Li, B., Zheng, L., Yang, J., & Qu, L. (2024) · Advanced Biotechnology · doi:10.1007/s44307-024-00030-y · Cited by 13
Ramireddy, S., & Sudandiradoss, C. (2017) · Functional & Integrative Genomics · doi:10.1007/s10142-017-0579-3 · Cited by 12
Xiu, D., Wang, D., Wang, J., Ji, F., & Zhang, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.9838 · Cited by 12
A novel pathogenic classification of cancers
Sonnenschein, C., Davis, B. J., & Soto, A. M. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0113-9 · Cited by 14
The Wnt Target Gene L1 in Colon Cancer Invasion and Metastasis
Haase, G., Gavert, N. S., Brabletz, T., & Ben‐Ze'ev, A. (2016) · Cancers · doi:10.3390/cancers8050048 · Cited by 11
Parallels between the extracellular matrix roles in developmental biology and cancer biology
Yuzhalin, A. E. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.09.010 · Cited by 11
Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells
Wang, R., Qi, B., Dong, Y. W., Cai, Q., Deng, N. H., Chen, Q., Li, C., Jin, Y. T., & Wu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9095 · Cited by 10
Integrin β4 in EMT: an implication of renal diseases.
Wang, Q., Wang, Y., Huang, X., Liang, W., Xiong, Z., & Xiong, Z. (2015) · Europe PMC (PubMed Central) · Cited by 10
Lee, M.-J., Seok, J., Saha, S. K., Cho, S., Jeong, Y., Gil, M., Kim, A., Shin, H. Y., Bae, H., Tae, J., et al. (2023) · International Journal of Stem Cells · doi:10.15283/ijsc22188 · Cited by 9
Engineering Mammary Gland in Vitro Models for Cancer Diagnostics and Therapy
Campbell, J. J., Hume, R. D., & Watson, C. J. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500121c · Cited by 9
LIM and SH3 protein 1 promotes tumor proliferation and metastasis in lung carcinoma
Lin, X., Liu, X., Fang, Y., & Weng, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.5225 · Cited by 8
Deciphering global signal features of high-throughput array data from cancers
Wu, D., Kang, J., Huang, Y., Li, X., Wang, X., Huang, D., Wang, Y., Li, B., Hao, D., Gu, Q., et al. (2014) · Molecular BioSystems · doi:10.1039/c4mb00084f · Cited by 8
Microtubule regulation in cancer cells
Matov, A. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1677302 · Cited by 7
Small Ones to Fight a Big Problem—Intervention of Cancer Metastasis by Small Molecules
Kobelt, D., Dahlmann, M., Dumbani, M., Güllü, N., Kortüm, B., Vílchez, M. E. A., Stein, U., & Walther, W. (2020) · Cancers · doi:10.3390/cancers12061454 · Cited by 7
A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil
Zhang, J., Zhang, S., Shi, Q., Allen, T. D., You, F., & Yang, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248355 · Cited by 7
Self-citationZhang, C., Cao, P., Yang, A., Xia, X., Li, Y., Shi, M., Yang, Y., Wei, X., Yang, C., & Zhou, G. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy146 · Cited by 7
To be or not to be a proliferation marker?
Blanchard, J. (2013) · Oncogene · doi:10.1038/onc.2013.19 · Cited by 6
Shkreta, L., Toutant, J., Delannoy, A., Durantel, D., Salvetti, A., Ehresmann, S., Sauvageau, M., Delbrouck, J. A., Gravel-Trudeau, A., Comeau, C., et al. (2024) · Oncotarget · doi:10.18632/oncotarget.28585 · Cited by 7
Sun, J. Y., Zhang, J., Wang, D., & Shen, J. (2020) · Biology Open · doi:10.1242/bio.048850 · Cited by 4
Nadal, R., Salido, M., Nonell, L., Rodríguez‐Rivera, M., Puigdecanet, E., García-Puche, J. L., Macià, M., Corominas, J. M., Serrano, M. J., Lorente, J. A., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2668-4 · Cited by 3
Suppression of RNA interference on expression of c-myc of SKOV3 ovarian carcinoma cell line.
Ai, Z., Wang, J., Yl, X., Xl, Z., & Yc, T. (2013) · PubMed · Cited by 3
Defining the Influence of Germline Variation on Metastasis Using Systems Genetics Approaches
Lee, M., & Crawford, N. P. S. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.07.003 · Cited by 3
Villanueva, D. A., Maqueda, M., Harti, D., Cantón, E., Andrades, E., Bertran, J., Martínez‐Iniesta, M., Solé, L., García‐Hernández, V., Montoto, Á., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68169-3 · Cited by 4
BRD4L cooperates with MYC to block local tumor invasion via suppression of S100A10
Ma, Y., Liu, N., Shi, Y., Ma, S., Wang, Y., Zheng, W., Sun, R., Song, Y., Chen, M., Qu, L., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111173 · Cited by 2
Sidechain structure–activity relationships of cyclobutane-based small molecule αvβ3 antagonists
Throup, A., Zraikat, M. S., Gordon, A. H., Soumehsaraei, S. J., Haase, K. D., Patterson, L. H., Cooper, P. A., Hanlon, K. E., Loadman, P. M., Sutherland, M., et al. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00306c · Cited by 2
Somatic Mutation Theory/Tissue Organization Field Theory: Has the Premise been Wrong All along?
Anand, R. (2016) · World Journal of Dentistry · doi:10.5005/jp-journals-10015-1388 · Cited by 2
Huang, Y., Yuan, T.-M., Liu, B., Liang, R., Liu, K., & Chuang, S. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108314 · Cited by 1
PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis
Zhu, B., Ma, N., Liu, Z., Zheng, Q., Liang, X., Chen, Y., Wang, Y., Cao, H., Xia, J., Xu, S., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012044 · Cited by 2
Gromova, O. A., Torshin, I. Y., & Дикке, Г. Б. (2026) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2026.724 · Cited by 1
Tan, S. C. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3308 · Cited by 1
Key LncRNAs Associated with Distant Metastasis in Breast Cancer: A System Biology Analysis
Mohammadi, S., Dehghani-Samani, M., Firouzi-Farsani, K., Dibaj, M., & Zhaeentan, S. (2024) · MicroRNA · doi:10.2174/0122115366319044241015065537 · Cited by 1
MYC retards cancer cell migration through suppressing fibronectin expression
Zhao, M., Jiang, P., & Du, W. (2019) · 中国科学通报:英文版 · doi:10.1016/j.scib.2019.04.027 · Cited by 1
Masha, A., Ben, G.-P. N., Cohen, E. I., Yvonne, V., & Vago, R. (2020) · Open Journal of Orthopedics and Rheumatology · doi:10.17352/ojor.000025 · Cited by 1
Berg, S. I. T. (2015) · UWSpace (University of Waterloo) · Cited by 1
IDENTIFICATION AND CHARACTERIZATION OF CIP2A AS A NOVEL ONCOGENIC INHIBITOR OF PP2A
Niemelä, M. (2012) · UTUPub (University of Turku)
Prediction of Molecular Mechanisms of Breast Cancer MetastasisPreprint
Siwo, G., Stolovitzky, G. A., & Assefa, S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/106179
Wu, Z., Chen, S., Shen, Z., Wu, T., Li, J., Feng, Y., Zhang, L., Huang, L., Guo, L., Qiao, X., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1936030/v1
Network-Based Method for the Identification of Genes Related to Cancer Metastasis
田, 智. (2023) · Pure Mathematics · doi:10.12677/pm.2023.135130
Decoding Peto's paradox in carcinogenesis: An insight
Anand, R., Sarode, G. S., Pandiar, D., Sengupta, N., & Sarode, S. C. (2023) · Oral Oncology Reports · doi:10.1016/j.oor.2023.100070
Sameri, S., Das, D., Shahrivari, S., Milosevic, V., Sarhadi, S., Koerkel-Qu, H., Fisch, C., Kokal, M., Schletter, M., Hahn, P. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.28.559965
Dewangan, N. R., Agrawal, P. P., Sahu, P., Sahu, D., Yadav, M., Gupta, P., & Ahirwar, B. (2024) · The Natural Products Journal · doi:10.2174/0122103155293700240408043538 · Cited by 1
Investigating the role of the centromeric histone variant CENP-A in cancer
Renaud-Pageot, C. (2024) · theses.fr (ABES) · doi:10.70675/eb41b5bfz0c52z4889z9d8czf04f426b8666
MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription
Sundaram, R. K., Parihar, K., Monson, S., Radhakrishnan, R., & Lim, B. (2026) · NAR Cancer · doi:10.1093/narcan/zcag010
Placenta-Specific miRNA miR-515-3p Suppresses HMGB3 Expression in the Breast Cancer Cell Line MCF-7
Sato, A., Takei, H., Noguchi, S., & Takizawa, T. (2026) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2026_93-206
Molecular mechanisms of microRNA-92b during tumor progression and metastasis
Maharati, A., & Moghbeli, M. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101513
Metadata
- Authors
- Liu, H., Radisky, D. C., Yang, D., Xu, R., Radisky, E. S., Bissell, M. J., & Bishop, J. M.
- Affiliations
- University of California, San Francisco (US)
- Mayo Clinic in Florida (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Radisky, Derek C.
- Venue
- Nature Cell Biology
- Published
- 2012-05-13
- Volume
- 14
- Issue
- 6
- Pages
- 567-574
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3366024
- OpenAlex
- W1480621946
- Cited by
- 181
- References
- 51
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 12 · 2019: 6 · 2018: 24 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 25 · 2013: 18 · 2012: 6
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA122086, U54CA126552, CA-116201, R01CA122086, U54CA143836, R37CA064786, U01CA143233, P50CA091956, P50CA116201)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- c-Myc, metastasis suppression, integrin αvβ3, CD61, ITGAV, transcriptional repression, cell migration, cell invasion, breast cancer, lung metastasis, liver metastasis, tumor xenografts
- MeSH terms
- Animals, Extracellular Matrix, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Transcription, Genetic, Proto-Oncogene Proteins c-myc, Gene Silencing, Protein Subunits, Integrin alpha5, Integrin beta3, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review